Melanoma/Skin Cancer News

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

The noninvasive 2-gene expression profiling assay test has the ability to rule out melanoma with a negative predictive value over 99%, according to a real-world study presented at the Winter Clinical Conference.

The FDA has granted accelerated approval to a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma.

Quest Diagnostics has launched MelaNodal Predict, an advanced predictive gene expression test for patients with melanoma, the company announced in a press release.

MIAMI BEACH, Fla. — Patients who are elderly or are poor candidates for surgery with nonmelanoma skin cancer would benefit from superficial radiation therapy, according to a speaker at South Beach Symposium.

Researchers have harnessed the ability of some molecules to vibrate strongly when stimulated by light, potentially laying the groundwork for a new approach to destroying cancer cells.

Patients with melanoma who smoke have a higher risk for melanoma-related death, according to a study.

The supplemental new drug application for Ameluz has received a “no filing review issues identified” letter from the FDA, according to a press release.

As the broader health care field strives to identify and address health care disparities, a commentary published in The Lancet Oncology underscored the importance of eliminating ableism from cancer care.

The proportion of individuals with newly diagnosed cancer who lacked insurance in the U.S. declined significantly from 2010 to 2019, according to data published in Health Affairs Scholar.